Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TNBC”

470 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 470 results

Testing effectiveness (Phase 2)WithdrawnNCT03872505
What this trial is testing

Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Cedars-Sinai Medical Center
Early research (Phase 1)Active Not RecruitingNCT05174637
What this trial is testing

FDA018-ADC in Patients With Advanced Solid Tumors

Who this might be right for
Advanced/ Metastatic Solid Tumors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT02719691
What this trial is testing

Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer

Who this might be right for
Metastatic Breast CancerSolid Tumors
University of Colorado, Denver 47
Very early researchStudy completedNCT01467310
What this trial is testing

Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 15
Not applicableNot Yet RecruitingNCT06418139
What this trial is testing

Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy

Who this might be right for
Non-Metastatic Breast Carcinoma
Assistance Publique - Hôpitaux de Paris 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298
What this trial is testing

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
National Cancer Center, Korea 284
Large-scale testing (Phase 3)Not Yet RecruitingNCT07407517
What this trial is testing

Adjuvant Intensification for LAR

Who this might be right for
Breast Cancer FemalesTriple Negative Breast Cancer (TNBC)
Fudan University 904
Early research (Phase 1)Active Not RecruitingNCT05891171
What this trial is testing

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Who this might be right for
Advanced CancerAdvanced MalignanciesBladder Cancer+9 more
Arcus Biosciences, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT03519178
What this trial is testing

PF-06873600 in People With Cancer

Who this might be right for
HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
Pfizer 155
Testing effectiveness (Phase 2)Ended earlyNCT03901469
What this trial is testing

ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Zenith Epigenetics 115
Early research (Phase 1)Looking for participantsNCT07190469
What this trial is testing

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC)Advanced Solid Tumors Cancer
ProteinQure Inc. 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT06910072
What this trial is testing

Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07080619
What this trial is testing

SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers

Who this might be right for
TNBC - Triple-Negative Breast CancerHR+ Breast Cancer
Tianjin ConjuStar Biologics Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07011654
What this trial is testing

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

Who this might be right for
Metastatic Triple-Negative Breast Cancer
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07134556
What this trial is testing

Phase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBC

Who this might be right for
Triple Negative Breast CancerPDL-1 Positive
MedSIR 25
Testing effectiveness (Phase 2)Study completedNCT03289819
What this trial is testing

Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC

Who this might be right for
Malignant Neoplasm of Breast
Institut fuer Frauengesundheit 53
Large-scale testing (Phase 3)Looking for participantsNCT06081244
What this trial is testing

NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)

Who this might be right for
Triple Negative Breast Cancer
West German Study Group 348
Testing effectiveness (Phase 2)Looking for participantsNCT07016399
What this trial is testing

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Triple-Negative Breast Carcinoma
Vandana Abramson 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07069595
What this trial is testing

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

Who this might be right for
Breast CancerResidual DiseaseTriple Negative Breast Cancer (TNBC)+1 more
UNC Lineberger Comprehensive Cancer Center 78
Not applicableLooking for participantsNCT02302742
What this trial is testing

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Who this might be right for
Breast CancerHereditary Breast and Ovarian Cancer
University of Kansas Medical Center 1,500
Load More Results